Refine Search
(337)
(518)
(621)
(621)

Schizophrenia - Pipeline Review, H1 2017

  • $2,000
  • May 2017
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Schizophrenia - Pipeline Review, H1 2017’, provides an overview of the Schizophrenia pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Schizophrenia, com...

Amyotrophic Lateral Sclerosis - Pipeline Review, H1 2017

  • $2,000
  • May 2017
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Amyotrophic Lateral Sclerosis - Pipeline Review, H1 2017’, provides an overview of the Amyotrophic Lateral Sclerosis pipeline landscape.

The report provides comprehensive information on the therapeutics under de...

Insomnia - Pipeline Review, H1 2017

  • $2,000
  • May 2017
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Insomnia - Pipeline Review, H1 2017’, provides an overview of the Insomnia pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Insomnia, complete with anal...

Systemic Mastocytosis - Pipeline Review, H1 2017

  • $2,000
  • May 2017
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Systemic Mastocytosis - Pipeline Review, H1 2017’, provides an overview of the Systemic Mastocytosis pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Sy...

Migraine - Pipeline Review, H1 2017

  • $2,000
  • May 2017
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Migraine - Pipeline Review, H1 2017’, provides an overview of the Migraine pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Migraine, complete with anal...

Cancer Pain - Pipeline Review, H1 2017

  • $2,000
  • May 2017
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Cancer Pain - Pipeline Review, H1 2017’, provides an overview of the Cancer Pain pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Cancer Pain, complete ...

Spinal Cord Injury - Pipeline Review, H1 2017

  • $2,000
  • May 2017
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Spinal Cord Injury - Pipeline Review, H1 2017’, provides an overview of the Spinal Cord Injury pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Spinal C...

Gastritis - Pipeline Review, H1 2017

  • $2,000
  • May 2017
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Gastritis - Pipeline Review, H1 2017’, provides an overview of the Gastritis pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Gastritis, complete with a...

Endometriosis - Pipeline Review, H1 2017

  • $2,000
  • May 2017
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Endometriosis - Pipeline Review, H1 2017’, provides an overview of the Endometriosis pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Endometriosis, com...

Osteoarthritis Pain - Pipeline Review, H1 2017

  • $2,000
  • May 2017
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Osteoarthritis Pain - Pipeline Review, H1 2017’, provides an overview of the Osteoarthritis Pain pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Osteoa...

Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) - Pipeline Review, H1 2017

  • $2,000
  • May 2017
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) - Pipeline Review, H1 2017’, provides an overview of the Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) pipeline landscape.

Th...

Guillain-Barre Syndrome - Pipeline Review, H1 2017

  • $2,000
  • May 2017
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Guillain-Barre Syndrome - Pipeline Review, H1 2017’, provides an overview of the Guillain-Barre Syndrome pipeline landscape.

The report provides comprehensive information on the therapeutics under development fo...

Low Back Pain - Pipeline Review, H1 2017

  • $2,000
  • May 2017
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Low Back Pain - Pipeline Review, H1 2017’, provides an overview of the Low Back Pain pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Low Back Pain, com...

Rett Syndrome - Pipeline Review, H1 2017

  • $2,000
  • May 2017
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Rett Syndrome - Pipeline Review, H1 2017’, provides an overview of the Rett Syndrome pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Rett Syndrome, com...

Binge Eating Disorder - Pipeline Review, H1 2017

  • $2,000
  • May 2017
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Binge Eating Disorder - Pipeline Review, H1 2017’, provides an overview of the Binge Eating Disorder pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Bi...